Digital Therapeutics Market

The Digital Therapeutics market consists of clinically-validated software applications designed to treat, manage, or prevent diseases. The primary customers are employers, who offer these services as employee benefits, and patients, particularly those with chronic conditions like diabetes and cardiovascular diseases. Key growth drivers for this market include the global increase in internet access and significant government initiatives aimed at digitalizing the healthcare ecosystem.

CAGR

27.5%

Compound Annual Growth Rate

Current Value

$12.8B

Estimated 2026

Projected Value

$89.4B

By 2034